 NEW HAVEN, Conn., Dec. 14, 2022 GLOBE NEWSWIRE BIOASIS TECHNOLOGIES INC. TSXV:BTI OTCQB:BIOAF, the Company or Bioasis, a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and a differentiated, proprietary xB3 TM platform for delivering therapeutics across the blood-brain barrier BBB and the treatment of central ... The post Bioasis Technologies Inc. Announces Shareholder Webinar appeared first on Fo... 